Diagnostic value of electrocardiographic P-wave characteristics in atrial fibrillation recurrence and tachycardia-induced cardiomyopathy after catheter ablation

Abnormal P-wave characteristics were reportedly associated with left ventricular interstitial fibrosis as defined by cardiac magnetic resonance images. The objective of this study is to investigate the utility of P-wave characteristics to predict atrial fibrillation (AF) recurrence and the recovery...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart and vessels 2018-11, Vol.33 (11), p.1381-1389
Hauptverfasser: Doi, Atsushi, Takagi, Masahiko, Katayama, Hisashi, Yoshiyama, Tomotaka, Hayashi, Yusuke, Tatsumi, Hiroaki, Yoshiyama, Minoru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1389
container_issue 11
container_start_page 1381
container_title Heart and vessels
container_volume 33
creator Doi, Atsushi
Takagi, Masahiko
Katayama, Hisashi
Yoshiyama, Tomotaka
Hayashi, Yusuke
Tatsumi, Hiroaki
Yoshiyama, Minoru
description Abnormal P-wave characteristics were reportedly associated with left ventricular interstitial fibrosis as defined by cardiac magnetic resonance images. The objective of this study is to investigate the utility of P-wave characteristics to predict atrial fibrillation (AF) recurrence and the recovery of left ventricular systolic dysfunction (LVSD) after catheter ablation (CA) for AF. Two hundred and five AF patients (109 paroxysmal and 96 persistent) who underwent CA were enrolled. We measured maximum P-wave duration (max PWD) and P-wave terminal force in lead V1 (PTFV1) calculated as a product of P-wave terminal amplitude (PTaV1) and duration (PTdV1) in lead V1 during sinus rhythm. AF recurrence was noted in 50 patients at 12 months after CA. Patients with AF recurrence had a higher prevalence of persistent AF, a larger left atrial volume, and a longer max PWD than those without. We divided the patients into 2 groups: 156 patients with left ventricular ejection fraction (LVEF) > 45% and 49 patients with LVEF ≤ 45% (Low-EF group). In Low-EF group, tachycardia-induced cardiomyopathy (TIC) was defined as improvement in LVEF ≥ 15% or LVEF ≥ 50% at 5 months after CA. TIC and non-TIC groups consisted of 37 and 12 patients, respectively. Max PWD, PTFV1, PTdV1, and PTaV1 were significantly greater in non-TIC-group than in TIC-group. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups; cut-off value for PTFV1 was determined as 56.7 mV ms (area under the ROC curve = 0.80; 75% sensitivity; and 76% specificity). Max PWD was a useful predictor of AF recurrence and the complete recovery of LVSD after CA. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups.
doi_str_mv 10.1007/s00380-018-1179-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2033382092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2033382092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-1c397ea3a0cc14b71ac5c098a899ec5c8d05d134d560600ce363c1f3535402033</originalsourceid><addsrcrecordid>eNp1kcuO1DAQRS0EYpqBD2CDLLFhY6iK8_ISDU9pJFjAOqp2Kh2P0nFjO4P6b_hUHDKAhMTKJdep48cV4inCSwRoXkUA3YICbBViY1R5T-ywxkoVVaPvix0YBNXqorkQj2K8AcDKoHkoLgrToG4L2IkfbxwdZh-Ts_KWpoWlHyRPbFPwlkLv_CHQaczdz-o73bK0IwWyiYNbZ6J0s6QUHE1ycPvgpomS87MMbJcQeLYsae5lIjuef_lIublfLPdy0x_P_kRpPEsasjRvppHXgvab6bF4MNAU-cndeim-vnv75eqDuv70_uPV62tly7pICq02DZMmsBbLfYNkKwumpdYYzmXbQ9WjLvuqhhrAsq61xUFXuiqhAK0vxYvNewr-28IxdUcXLef3zOyX2K3M-mWmyOjzf9Abv4Q5326lihqbWq8UbpQNPsbAQ3cK7kjh3CF0a3zdFl-X4-vW-Loyzzy7My_7I_d_Jn7nlYFiA2JuzQcOf4_-v_Un3AuodA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2032617632</pqid></control><display><type>article</type><title>Diagnostic value of electrocardiographic P-wave characteristics in atrial fibrillation recurrence and tachycardia-induced cardiomyopathy after catheter ablation</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Doi, Atsushi ; Takagi, Masahiko ; Katayama, Hisashi ; Yoshiyama, Tomotaka ; Hayashi, Yusuke ; Tatsumi, Hiroaki ; Yoshiyama, Minoru</creator><creatorcontrib>Doi, Atsushi ; Takagi, Masahiko ; Katayama, Hisashi ; Yoshiyama, Tomotaka ; Hayashi, Yusuke ; Tatsumi, Hiroaki ; Yoshiyama, Minoru</creatorcontrib><description>Abnormal P-wave characteristics were reportedly associated with left ventricular interstitial fibrosis as defined by cardiac magnetic resonance images. The objective of this study is to investigate the utility of P-wave characteristics to predict atrial fibrillation (AF) recurrence and the recovery of left ventricular systolic dysfunction (LVSD) after catheter ablation (CA) for AF. Two hundred and five AF patients (109 paroxysmal and 96 persistent) who underwent CA were enrolled. We measured maximum P-wave duration (max PWD) and P-wave terminal force in lead V1 (PTFV1) calculated as a product of P-wave terminal amplitude (PTaV1) and duration (PTdV1) in lead V1 during sinus rhythm. AF recurrence was noted in 50 patients at 12 months after CA. Patients with AF recurrence had a higher prevalence of persistent AF, a larger left atrial volume, and a longer max PWD than those without. We divided the patients into 2 groups: 156 patients with left ventricular ejection fraction (LVEF) &gt; 45% and 49 patients with LVEF ≤ 45% (Low-EF group). In Low-EF group, tachycardia-induced cardiomyopathy (TIC) was defined as improvement in LVEF ≥ 15% or LVEF ≥ 50% at 5 months after CA. TIC and non-TIC groups consisted of 37 and 12 patients, respectively. Max PWD, PTFV1, PTdV1, and PTaV1 were significantly greater in non-TIC-group than in TIC-group. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups; cut-off value for PTFV1 was determined as 56.7 mV ms (area under the ROC curve = 0.80; 75% sensitivity; and 76% specificity). Max PWD was a useful predictor of AF recurrence and the complete recovery of LVSD after CA. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups.</description><identifier>ISSN: 0910-8327</identifier><identifier>EISSN: 1615-2573</identifier><identifier>DOI: 10.1007/s00380-018-1179-4</identifier><identifier>PMID: 29713820</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Ablation ; Adult ; Aged ; Aged, 80 and over ; Atrial Fibrillation - complications ; Atrial Fibrillation - diagnosis ; Atrial Fibrillation - surgery ; Biomedical Engineering and Bioengineering ; Cardiac arrhythmia ; Cardiac Surgery ; Cardiology ; Cardiomyopathies - diagnosis ; Cardiomyopathies - etiology ; Cardiomyopathies - physiopathology ; Cardiomyopathy ; Catheter Ablation - methods ; Catheters ; Diagnostic systems ; Echocardiography ; Electrocardiography ; Female ; Fibrillation ; Fibrosis ; Heart ; Heart Conduction System - physiopathology ; Heart Conduction System - surgery ; Heart diseases ; Heart Ventricles - diagnostic imaging ; Heart Ventricles - physiopathology ; Humans ; Magnetic resonance imaging ; Male ; Medical instruments ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Original Article ; Patients ; Pulmonary Veins - surgery ; Radiofrequency ablation ; Recovery ; Recurrence ; Risk Factors ; ROC Curve ; Tachycardia ; Vascular Surgery ; Ventricle ; Ventricular Function, Left - physiology ; Young Adult</subject><ispartof>Heart and vessels, 2018-11, Vol.33 (11), p.1381-1389</ispartof><rights>Springer Japan KK, part of Springer Nature 2018</rights><rights>Heart and Vessels is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-1c397ea3a0cc14b71ac5c098a899ec5c8d05d134d560600ce363c1f3535402033</citedby><cites>FETCH-LOGICAL-c462t-1c397ea3a0cc14b71ac5c098a899ec5c8d05d134d560600ce363c1f3535402033</cites><orcidid>0000-0002-2076-2796</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00380-018-1179-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00380-018-1179-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29713820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Doi, Atsushi</creatorcontrib><creatorcontrib>Takagi, Masahiko</creatorcontrib><creatorcontrib>Katayama, Hisashi</creatorcontrib><creatorcontrib>Yoshiyama, Tomotaka</creatorcontrib><creatorcontrib>Hayashi, Yusuke</creatorcontrib><creatorcontrib>Tatsumi, Hiroaki</creatorcontrib><creatorcontrib>Yoshiyama, Minoru</creatorcontrib><title>Diagnostic value of electrocardiographic P-wave characteristics in atrial fibrillation recurrence and tachycardia-induced cardiomyopathy after catheter ablation</title><title>Heart and vessels</title><addtitle>Heart Vessels</addtitle><addtitle>Heart Vessels</addtitle><description>Abnormal P-wave characteristics were reportedly associated with left ventricular interstitial fibrosis as defined by cardiac magnetic resonance images. The objective of this study is to investigate the utility of P-wave characteristics to predict atrial fibrillation (AF) recurrence and the recovery of left ventricular systolic dysfunction (LVSD) after catheter ablation (CA) for AF. Two hundred and five AF patients (109 paroxysmal and 96 persistent) who underwent CA were enrolled. We measured maximum P-wave duration (max PWD) and P-wave terminal force in lead V1 (PTFV1) calculated as a product of P-wave terminal amplitude (PTaV1) and duration (PTdV1) in lead V1 during sinus rhythm. AF recurrence was noted in 50 patients at 12 months after CA. Patients with AF recurrence had a higher prevalence of persistent AF, a larger left atrial volume, and a longer max PWD than those without. We divided the patients into 2 groups: 156 patients with left ventricular ejection fraction (LVEF) &gt; 45% and 49 patients with LVEF ≤ 45% (Low-EF group). In Low-EF group, tachycardia-induced cardiomyopathy (TIC) was defined as improvement in LVEF ≥ 15% or LVEF ≥ 50% at 5 months after CA. TIC and non-TIC groups consisted of 37 and 12 patients, respectively. Max PWD, PTFV1, PTdV1, and PTaV1 were significantly greater in non-TIC-group than in TIC-group. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups; cut-off value for PTFV1 was determined as 56.7 mV ms (area under the ROC curve = 0.80; 75% sensitivity; and 76% specificity). Max PWD was a useful predictor of AF recurrence and the complete recovery of LVSD after CA. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups.</description><subject>Ablation</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - surgery</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Cardiac arrhythmia</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Cardiomyopathies - diagnosis</subject><subject>Cardiomyopathies - etiology</subject><subject>Cardiomyopathies - physiopathology</subject><subject>Cardiomyopathy</subject><subject>Catheter Ablation - methods</subject><subject>Catheters</subject><subject>Diagnostic systems</subject><subject>Echocardiography</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Fibrillation</subject><subject>Fibrosis</subject><subject>Heart</subject><subject>Heart Conduction System - physiopathology</subject><subject>Heart Conduction System - surgery</subject><subject>Heart diseases</subject><subject>Heart Ventricles - diagnostic imaging</subject><subject>Heart Ventricles - physiopathology</subject><subject>Humans</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Medical instruments</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Patients</subject><subject>Pulmonary Veins - surgery</subject><subject>Radiofrequency ablation</subject><subject>Recovery</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>ROC Curve</subject><subject>Tachycardia</subject><subject>Vascular Surgery</subject><subject>Ventricle</subject><subject>Ventricular Function, Left - physiology</subject><subject>Young Adult</subject><issn>0910-8327</issn><issn>1615-2573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kcuO1DAQRS0EYpqBD2CDLLFhY6iK8_ISDU9pJFjAOqp2Kh2P0nFjO4P6b_hUHDKAhMTKJdep48cV4inCSwRoXkUA3YICbBViY1R5T-ywxkoVVaPvix0YBNXqorkQj2K8AcDKoHkoLgrToG4L2IkfbxwdZh-Ts_KWpoWlHyRPbFPwlkLv_CHQaczdz-o73bK0IwWyiYNbZ6J0s6QUHE1ycPvgpomS87MMbJcQeLYsae5lIjuef_lIublfLPdy0x_P_kRpPEsasjRvppHXgvab6bF4MNAU-cndeim-vnv75eqDuv70_uPV62tly7pICq02DZMmsBbLfYNkKwumpdYYzmXbQ9WjLvuqhhrAsq61xUFXuiqhAK0vxYvNewr-28IxdUcXLef3zOyX2K3M-mWmyOjzf9Abv4Q5326lihqbWq8UbpQNPsbAQ3cK7kjh3CF0a3zdFl-X4-vW-Loyzzy7My_7I_d_Jn7nlYFiA2JuzQcOf4_-v_Un3AuodA</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Doi, Atsushi</creator><creator>Takagi, Masahiko</creator><creator>Katayama, Hisashi</creator><creator>Yoshiyama, Tomotaka</creator><creator>Hayashi, Yusuke</creator><creator>Tatsumi, Hiroaki</creator><creator>Yoshiyama, Minoru</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2076-2796</orcidid></search><sort><creationdate>20181101</creationdate><title>Diagnostic value of electrocardiographic P-wave characteristics in atrial fibrillation recurrence and tachycardia-induced cardiomyopathy after catheter ablation</title><author>Doi, Atsushi ; Takagi, Masahiko ; Katayama, Hisashi ; Yoshiyama, Tomotaka ; Hayashi, Yusuke ; Tatsumi, Hiroaki ; Yoshiyama, Minoru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-1c397ea3a0cc14b71ac5c098a899ec5c8d05d134d560600ce363c1f3535402033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Ablation</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - surgery</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Cardiac arrhythmia</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Cardiomyopathies - diagnosis</topic><topic>Cardiomyopathies - etiology</topic><topic>Cardiomyopathies - physiopathology</topic><topic>Cardiomyopathy</topic><topic>Catheter Ablation - methods</topic><topic>Catheters</topic><topic>Diagnostic systems</topic><topic>Echocardiography</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Fibrillation</topic><topic>Fibrosis</topic><topic>Heart</topic><topic>Heart Conduction System - physiopathology</topic><topic>Heart Conduction System - surgery</topic><topic>Heart diseases</topic><topic>Heart Ventricles - diagnostic imaging</topic><topic>Heart Ventricles - physiopathology</topic><topic>Humans</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Medical instruments</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Patients</topic><topic>Pulmonary Veins - surgery</topic><topic>Radiofrequency ablation</topic><topic>Recovery</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>ROC Curve</topic><topic>Tachycardia</topic><topic>Vascular Surgery</topic><topic>Ventricle</topic><topic>Ventricular Function, Left - physiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Doi, Atsushi</creatorcontrib><creatorcontrib>Takagi, Masahiko</creatorcontrib><creatorcontrib>Katayama, Hisashi</creatorcontrib><creatorcontrib>Yoshiyama, Tomotaka</creatorcontrib><creatorcontrib>Hayashi, Yusuke</creatorcontrib><creatorcontrib>Tatsumi, Hiroaki</creatorcontrib><creatorcontrib>Yoshiyama, Minoru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart and vessels</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Doi, Atsushi</au><au>Takagi, Masahiko</au><au>Katayama, Hisashi</au><au>Yoshiyama, Tomotaka</au><au>Hayashi, Yusuke</au><au>Tatsumi, Hiroaki</au><au>Yoshiyama, Minoru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic value of electrocardiographic P-wave characteristics in atrial fibrillation recurrence and tachycardia-induced cardiomyopathy after catheter ablation</atitle><jtitle>Heart and vessels</jtitle><stitle>Heart Vessels</stitle><addtitle>Heart Vessels</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>33</volume><issue>11</issue><spage>1381</spage><epage>1389</epage><pages>1381-1389</pages><issn>0910-8327</issn><eissn>1615-2573</eissn><abstract>Abnormal P-wave characteristics were reportedly associated with left ventricular interstitial fibrosis as defined by cardiac magnetic resonance images. The objective of this study is to investigate the utility of P-wave characteristics to predict atrial fibrillation (AF) recurrence and the recovery of left ventricular systolic dysfunction (LVSD) after catheter ablation (CA) for AF. Two hundred and five AF patients (109 paroxysmal and 96 persistent) who underwent CA were enrolled. We measured maximum P-wave duration (max PWD) and P-wave terminal force in lead V1 (PTFV1) calculated as a product of P-wave terminal amplitude (PTaV1) and duration (PTdV1) in lead V1 during sinus rhythm. AF recurrence was noted in 50 patients at 12 months after CA. Patients with AF recurrence had a higher prevalence of persistent AF, a larger left atrial volume, and a longer max PWD than those without. We divided the patients into 2 groups: 156 patients with left ventricular ejection fraction (LVEF) &gt; 45% and 49 patients with LVEF ≤ 45% (Low-EF group). In Low-EF group, tachycardia-induced cardiomyopathy (TIC) was defined as improvement in LVEF ≥ 15% or LVEF ≥ 50% at 5 months after CA. TIC and non-TIC groups consisted of 37 and 12 patients, respectively. Max PWD, PTFV1, PTdV1, and PTaV1 were significantly greater in non-TIC-group than in TIC-group. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups; cut-off value for PTFV1 was determined as 56.7 mV ms (area under the ROC curve = 0.80; 75% sensitivity; and 76% specificity). Max PWD was a useful predictor of AF recurrence and the complete recovery of LVSD after CA. PTFV1 had the highest diagnostic accuracy to discriminate between TIC and no-TIC-groups.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>29713820</pmid><doi>10.1007/s00380-018-1179-4</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-2076-2796</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0910-8327
ispartof Heart and vessels, 2018-11, Vol.33 (11), p.1381-1389
issn 0910-8327
1615-2573
language eng
recordid cdi_proquest_miscellaneous_2033382092
source MEDLINE; SpringerLink Journals
subjects Ablation
Adult
Aged
Aged, 80 and over
Atrial Fibrillation - complications
Atrial Fibrillation - diagnosis
Atrial Fibrillation - surgery
Biomedical Engineering and Bioengineering
Cardiac arrhythmia
Cardiac Surgery
Cardiology
Cardiomyopathies - diagnosis
Cardiomyopathies - etiology
Cardiomyopathies - physiopathology
Cardiomyopathy
Catheter Ablation - methods
Catheters
Diagnostic systems
Echocardiography
Electrocardiography
Female
Fibrillation
Fibrosis
Heart
Heart Conduction System - physiopathology
Heart Conduction System - surgery
Heart diseases
Heart Ventricles - diagnostic imaging
Heart Ventricles - physiopathology
Humans
Magnetic resonance imaging
Male
Medical instruments
Medicine
Medicine & Public Health
Middle Aged
Original Article
Patients
Pulmonary Veins - surgery
Radiofrequency ablation
Recovery
Recurrence
Risk Factors
ROC Curve
Tachycardia
Vascular Surgery
Ventricle
Ventricular Function, Left - physiology
Young Adult
title Diagnostic value of electrocardiographic P-wave characteristics in atrial fibrillation recurrence and tachycardia-induced cardiomyopathy after catheter ablation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T11%3A52%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20value%20of%20electrocardiographic%20P-wave%20characteristics%20in%20atrial%20fibrillation%20recurrence%20and%20tachycardia-induced%20cardiomyopathy%20after%20catheter%20ablation&rft.jtitle=Heart%20and%20vessels&rft.au=Doi,%20Atsushi&rft.date=2018-11-01&rft.volume=33&rft.issue=11&rft.spage=1381&rft.epage=1389&rft.pages=1381-1389&rft.issn=0910-8327&rft.eissn=1615-2573&rft_id=info:doi/10.1007/s00380-018-1179-4&rft_dat=%3Cproquest_cross%3E2033382092%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2032617632&rft_id=info:pmid/29713820&rfr_iscdi=true